Clinical Trials in Atlanta

Showing 11561-11580 of 19,805 trials

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

NCT00441883

This study will evaluate the safety and efficacy of PF 03187207.

Primary Open Angle GlaucomaOcular HypertensionPigmentary Glaucoma+1 more

Bausch & Lomb Incorporated176 participantsStarted Mar 2007

Artesia, California, United States • Newport Beach, California, United States • Petaluma, California, United States +16 more locations

TERMINATEDPhase 2< 1 mile

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

NCT03298412

The study will estimate the MRD-negative response rate after treatment with blinatumomab in subjects with high-risk DLBCL who are MRD-positive following aHSCT. The clinical hypothesis is that the MRD-negative response rate will be greater than 10%. Achieving an MRD-negative response rate of 30% would be of scientific and clinical interest.

High-risk Diffuse Large B-cell Lymphoma

Amgen10 participantsStarted May 2018

Atlanta, Georgia, United States • Maywood, Illinois, United States • Cleveland, Ohio, United States +29 more locations

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

Find Trials by Condition in Atlanta

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Oral Iron for Erythropoietic Protoporphyrias

Behavioral Therapy Of Obstetric Sphincter Tears

Randomized Evaluation of Default Access to Palliative Services

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

Electric-Acoustic Stimulation Extended Follow-up Post Approval Study

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation

An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Clinical Evaluation of Flortaucipir F 18

A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations